AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 201 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $60,858,020 | -5.1% | 2,458,891 | +8.6% | 0.02% | 0.0% |
| Q2 2023 | $64,109,168 | +33.5% | 2,263,818 | +8.2% | 0.02% | +25.0% |
| Q1 2023 | $48,037,412 | +103391.0% | 2,091,351 | +26.5% | 0.02% | +14.3% |
| Q4 2022 | $46,417 | -99.9% | 1,653,079 | +11.8% | 0.01% | -12.5% |
| Q3 2022 | $41,811,000 | +40.4% | 1,478,389 | +10.1% | 0.02% | +45.5% |
| Q2 2022 | $29,778,000 | +1.2% | 1,343,157 | +32.9% | 0.01% | +22.2% |
| Q1 2022 | $29,420,000 | +23.4% | 1,010,616 | +39.3% | 0.01% | +28.6% |
| Q4 2021 | $23,845,000 | -4.4% | 725,401 | +34.2% | 0.01% | -12.5% |
| Q3 2021 | $24,944,000 | +59.5% | 540,498 | +90.5% | 0.01% | +60.0% |
| Q2 2021 | $15,637,000 | +4.4% | 283,773 | -2.2% | 0.01% | 0.0% |
| Q1 2021 | $14,983,000 | +18.9% | 290,206 | -0.2% | 0.01% | 0.0% |
| Q4 2020 | $12,600,000 | +10.6% | 290,761 | -10.7% | 0.01% | 0.0% |
| Q3 2020 | $11,395,000 | -37.4% | 325,606 | -4.4% | 0.01% | -37.5% |
| Q2 2020 | $18,211,000 | +33.3% | 340,526 | -11.6% | 0.01% | +14.3% |
| Q1 2020 | $13,664,000 | -14.8% | 385,146 | +14.7% | 0.01% | +16.7% |
| Q4 2019 | $16,029,000 | +92.4% | 335,675 | +30.6% | 0.01% | +100.0% |
| Q3 2019 | $8,331,000 | -4.1% | 257,020 | +47.6% | 0.00% | 0.0% |
| Q2 2019 | $8,687,000 | -28.0% | 174,160 | -2.6% | 0.00% | -40.0% |
| Q1 2019 | $12,062,000 | +43.6% | 178,887 | -1.8% | 0.01% | +25.0% |
| Q4 2018 | $8,399,000 | -23.8% | 182,150 | +27.5% | 0.00% | 0.0% |
| Q3 2018 | $11,019,000 | +29.9% | 142,895 | +41.9% | 0.00% | +33.3% |
| Q2 2018 | $8,480,000 | +35.3% | 100,695 | +31.4% | 0.00% | 0.0% |
| Q1 2018 | $6,268,000 | +77.2% | 76,644 | +52.9% | 0.00% | +50.0% |
| Q3 2015 | $3,538,000 | -40.5% | 50,137 | -6.3% | 0.00% | -50.0% |
| Q2 2015 | $5,944,000 | +36.0% | 53,514 | +15.5% | 0.00% | +33.3% |
| Q1 2015 | $4,370,000 | +6.1% | 46,329 | +26.0% | 0.00% | 0.0% |
| Q4 2014 | $4,120,000 | – | 36,774 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
| Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
| Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
| ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
| Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
| ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
| Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |